| Trial ID: | L1065 |
| Source ID: | NCT03893799
|
| Associated Drug: |
Rbt-1
|
| Title: |
A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3-4 Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Kidney Injury
|
| Interventions: |
DRUG: RBT-1
|
| Outcome Measures: |
Primary: Safety and tolerability of RBT-1, Incidence of adverse events, 28 days |
|
| Sponsor/Collaborators: |
Sponsor: Renibus Therapeutics, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
54
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2019-08-27
|
| Completion Date: |
2020-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2022-01-11
|
| Locations: |
Riverside Clinical Research, Edgewater, Florida, 32141, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03893799
|
